Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Anti-TNF Therapy on Blood and Synovial Biomarkers in Active Rheumatoid Arthritis
2007-000593-24Phase 4Terminated
- Sponsor
- Roche
- Start
- Aug 2007
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of etanercept and adalimumab in rheumatoid arthritis (RA) (2 arms), sponsored by Roche. Primary endpoint: Baseline and longitudinal biomarker changes. Started Aug 2007; status: terminated.
02
Drugs
etanerceptadalimumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2007-000593-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000593-24.